MLSS MILESTONE SCIENTIFIC

Milestone Scientific Inc. Awarded Group Purchasing Agreement with Premier for CompuFlo® Epidural System and CathCheck™

Milestone Scientific Inc. Awarded Group Purchasing Agreement with Premier for CompuFlo® Epidural System and CathCheck™
EN
13/10/2020

Underlying

MLSSMILESTONE SCIENTIFIC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MILESTONE SCIENTIFIC

 PRESS RELEASE
Free
MLSS MILESTONE SCIEN...

Milestone Scientific Reports Financial Results for Fourth Quarter and ...

Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025 Q4 2025 Marks Transition from Restructuring to Growth For 2026, Expects Double-Digit Revenue Growth, 400% Increase in CompuFlo Sales, and Continued Progress Toward Profitability ROSELAND, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the year ended December 31, 2025. Eric Hines, Chi...

March 31, 2026 1 EN
 PRESS RELEASE
Free
MLSS MILESTONE SCIEN...

Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Re...

Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call ROSELAND, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, April 1, 2026, to discuss the company’s financial results for the fourth quarter and full year ended December 31, 2025, as well as the company’s corporate progress and other developments. ...

March 26, 2026 1 EN
 PRESS RELEASE
Free
MLSS MILESTONE SCIEN...

Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate ...

Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion ROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced the launch of the CompuFlo® Advisor Program. This strategic initiative is designed to drive mainstream commercial adoption, increase recurring disposable revenue, and generate the clinical data necessary...

February 23, 2026 1 EN
 PRESS RELEASE
Free
MLSS MILESTONE SCIEN...

Milestone Scientific Launches The Wand® Ambassador Program to Expand P...

Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry Pilot launched with six registered dental professionals; program expected to scale to 250 ambassadors over 12 months ROSELAND, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the launch of The Wand® Ambassador Program, a scalable peer-to-peer engagement initiative designed to expand clinical awareness, educ...

January 6, 2026 1 EN
 PRESS RELEASE
Free
MLSS MILESTONE SCIEN...

Milestone Scientific Delivers Stable Revenue and Reduces Operating Exp...

Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025 Company outlines continued progress executing operational transformation and growth strategy across its dental and medical segments ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced financial results and provided a business update for the third quarter ended September 30, 2025, highlighting continued ...

November 13, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch